期刊文献+

蛋白酶活化受体2在大鼠胆汁淤积性肝纤维化肝组织中的表达及其意义

Differential expression of protease-activated receptor 2 in a bile duct ligation-induced rat model of liver fibrosis
原文传递
导出
摘要 目的观察胆汁淤积陛肝纤维化大鼠肝组织中蛋白酶活化受体2(PAR2)的动态变化,探讨其在肝纤维化形成中的意义。方法建立大鼠胆汁淤积陛肝纤维化模型,同时设立假手术组和正常对照组,Westernblot及RT-PCR检测术后2、4、6、8周肝组织中PAR2蛋白及mRNA的表达水平,并分析其与I、Ⅲ型胶原表达水平的关系。对数据进行重复测量资料的方差分析。结果肝纤维化组大鼠2周时即可见PAR2mRNA及蛋白水平升高,随着肝纤维化时间的延长,4~6周时其表达水平进一步升高护〈0.05),8周时达高峰(相对表达量分别为1.62±0.11、47.6±2.8,P〈0.01)。I、Ⅲ型胶原蛋白表达水平也随着肝纤维化程度的加重而升高,6~8周时达高峰(相对表达量均为65.6±2.7),且与PAR2的表达水平呈一致陛。结论PAR,在胆汁淤积陛肝纤维化中的动态表达可能参与并促进肝纤维化的形成和发展。 Objective To observe the dynamic change in expression of protease-activated receptor 2 (PAR2) during onset and progression of liver fibrosis by using a rat model. Methods A cholestatic liver fibrosis model was established in Sprague-Dawley rats (aged 8-9 weeks, body weight 350 - 400 g) by bile duct ligation surgery. Rats receiving a sham operation and unoperated rats served as the negative and normal control groups, respectively. At baseline (pre-surgery) and post-surgery weeks 2, 4, 6, and 8, five rats from each group were sacrificed for whole liver resection. The protein and mRNA expressions of PAR2 and collagen I/Ⅲ were detected by western blotting and RT-PCR, respectively. Betwean-group differences were assessed by analysis of variance testing. Results At post-surgery week 2, the liver fibrosis group showed higher expression of PAR2 mRNA and protein than either control group. The expression levels of PARs continued to rise over time in the liver fibrosis group (peaking at week 8), and were significantly higher than those detected in the control groups (weeks 4-6: P 〈 0.05; week 8, P 〈 0.05). A similar trend was observed for the expression of collagen I/Ⅲ. Conclusion Dynamic expression of PARs observed in a cholestatic liver fibrosis rat model may indicate a role for this factor in the formation of liver fibrosis.
出处 《中华肝脏病杂志》 CAS CSCD 北大核心 2013年第5期363-366,共4页 Chinese Journal of Hepatology
基金 重庆市自然科学基金(2010BB5165) 中国人民解放军第三军医大学中青年基金(XG200543)
关键词 肝硬化 胆汁淤积 胶原 模型 动物 蛋白酶活化受体2 Liver cirrhosis Cholestasis Collagen Models, animal Proteas activated receptor-2
  • 相关文献

参考文献11

  • 1Adams MN, Ramachandran R, Yau MK, et al. Structure, function and pathophysiology of protease activated receptors. Pharmacol Ther, 2011,130: 248-282.
  • 2顾小红,房殿春,陈东风.胆管结扎大鼠肝纤维化模型中HSC的分离和培养及PAR_S的表达[J].胃肠病学和肝病学杂志,2006,15(5):474-477. 被引量:8
  • 3Henderson NC, Forbes SJ. Hepatic fibrogenesis: from within and outwith. Toxicology, 2008, 254: 130-135.
  • 4Ramachandran P, Iredale JP. Reversibility of liver fibrosis. Ann Hepatol, 2009, 8: 283-291.
  • 5Nystedt S, Emilsson K, Wahlestedt C, et a1. Molecular cloning of a potential proteinase activated receptor. Proc Nat! Acad Sci USA, 1994,91: 9208-9212.
  • 6Rullier A, Senant N, Kisiel W, et al, Expression of protease-activated receptors and tissue factor in human liver. Virchows Arch, 2006, 448: 46-51.
  • 7Ma L, Dorling A. The roles of thrombin and protease-activated receptors in inflammation. Semin Immunopathol, 2012, 34: 63-72.
  • 8Gaca MD, Zhou X, Benyon RC. Regulation of hepatic stellate cell proliferation and collagen synthesis by proteinase-activated receptors. J Hepatol, 2002, 36: 362-369.
  • 9顾小红,张云东,刘迎春.PAR_S调控大鼠HSC合成和分泌胶原蛋白的作用[J].重庆医科大学学报,2010,35(7):985-988. 被引量:4
  • 10Vergnolle N, Wallace JL, Bunnett NW, et al. Protease-activated receptors in inflammation, neuronal signaling and pain. Trends Pharmacol Sci, 2001, 22: 146-152.

二级参考文献43

  • 1Friedman S L,Roll F L.Isolation and culture of lipocytes,kupffer cells,andsinusoidal endothelial cells by density gradient centrifugation with stractan[J].Anal Biolchem,1987,161 (1):207-218.
  • 2Anstee Q M,Wright M,Goldin R,et al.Parenchymal extinction:coagulation and hepatic fibrogenesis[J].Clin Liver Dis,2009,13(1):117-126.
  • 3Park E J,Zhao Y Z,Lian L,et al.Skullcapflavone I from Scutellaria baicalensis induces apoptosis in activated rat hepatic stellate cells[J].Planta Med,2005,71 (9):885-887.
  • 4Guyot C,Lepreux S,Combe C,et al.Hepatic fibrosis and cirrhosis:The (myo)fibroblastic cell subpopulations involved[J].Int J Biochem Cell Biol,2006,38(2):135-151.
  • 5Anstee Q M,Coldin R D,Wright M,et al.Coagulation status modulates murine hepatic fibrogenesis:implications for the development of novel therapies[J].J Thromb Haemost,2008,6 (8):1334-1335.
  • 6Elsharkawy A M,Oakley F.Mann D A.The role and regulation of hepatic stellate cell apoptosis in reversal of liver fibrosis[J].Apoptosis,2005,10(5):927-939.
  • 7Constandinou C,Henderson N,Iredale J P.Modeling liver fibrosis in rodents[J].Methods Mol Med,2005,117:237-250.
  • 8Saile B N,Matthes,Neubauer K,et al.Rat liver myofibroblasts and hepatic stellate cells differ in CD95-mediated apoptosis and response to TNF-α[J].Am J Physiol Gastrointest Liver Physiol,2002,283(2):435-444.
  • 9Kaufmann R,Schulze B,Krause G,et al.Proteinase-activated receptors (PARs)-the PAR3 Neo-N-terminal peptide TFRGAP interacts with PAR1[J].Regul Pept,2005,125(1-3):61-66.
  • 10Suo Z,Wu M,Citron B A,et al.Persistent protease-activated receptor 4 signaling mediates thrombin-induced microglial activation[J].J Biol Chem,2003,278 (33):31177-31183.

共引文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部